Multibagger Inventory: 7500% bumper returns in 3 years, ₹ 1.5 lakhs grew to become ₹ 1 crore – INA NEWS

Multibagger Share: The inventory of a pharma sector firm has given a thick return of 7500 % to buyers inside 3 years. This multibagger has seen an increase of 1957 % in 2 years and 71 % within the yr 2025 up to now. The corporate is now going to separate inventory. We’re speaking about Venus Prescribed drugs. The corporate has mentioned within the trade submitting that it’ll break 1 share with a face worth of Rs 10 below the inventory cut up in 10 shares with a face worth of Rs 1.

The file date for that is 21 March 2025. The market cap of Venus Pharma is Rs 1000 crore. The share worth rose 285 % in 6 months. The corporate had a 50.96 % stake within the firm until the top of December 2024.

₹ 76 lakhs value ₹ 1 lakh in 3 years

Shukra Pharma’s inventory was priced at Rs 3.22, 3 years in the past on 14 March 2022 at BSE. The inventory closed at Rs 245.80 on 13 March 2025. Throughout this time, returns have been made 7533.54 %. If somebody would have invested 10000 rupees within the inventory 3 years in the past and wouldn’t have offered the shares within the center, then the funding in right now’s date would have turn out to be greater than 7 lakh rupees. Equally, Rs. 19 lakhs of Rs 25,000, Rs 38 lakh value Rs 50000, Rs 76 lakh for Rs 1 lakh and Rs 1.5 lakh could have been greater than Rs 1 crore.

Venus Pharma shares created a 52 -week excessive stage of Rs 271.50 (adjusted) on 5 March 2025 on BSE. The 52 -week low of 57.52 rupees (adjusted) was noticed on 21 November 2024. The higher circuit for the inventory is Rs 250.70 and the decrease circuit at Rs 240.90. The circuit restrict is 2 %.

Multibagger Inventory: 340% climbed from final Holi up to now, ₹ 1 lakh in 2 years made ₹ 33 lakh

Revenue in December quarter Rs 3 crore

Within the October-December 2024 quarter, Venus Pharma recorded a income of Rs 10.58 crore on the standalone foundation. Throughout this era, the corporate’s web revenue was Rs 3.16 crore and earnings was Rs 72 lakh per share. In FY 2024, Income was recorded at Rs 74.57 crore, web revenue of Rs 18.54 crore and Earnings Rs 16.93 crore per share.

Disclaimer: Right here the data offered is given on the idea of share efficiency. It’s essential to state that the funding out there is topic to market dangers. All the time seek the advice of consultants earlier than investing cash as an investor. There’s by no means recommendation to anybody to take a position cash on behalf of Moneycontrol.